title: Portopulmonary hypertension and hepatopulmonary syndrome: two different entities affecting pulmonary vasculature in liver disease.
authors.forename: Graciela
authors.initials: G
authors.lastname: Martinez-Pallí
authors.forename: Jaime Balust
authors.initials: JB
authors.lastname: Vidal
authors.forename: J
authors.initials: J
authors.lastname: Beltrán
authors.forename: Pilar
authors.initials: P
authors.lastname: Taurà
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage; D011464:Epoprostenol / Q000008:administration & dosage; D020065:Hepatopulmonary Syndrome / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology*; D006801:Humans; D006975:Hypertension, Portal / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology*; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology*; D017093:Liver Failure / Q000401:mortality / Q000503:physiopathology*; D016031:Liver Transplantation / Q000502:physiology*; D011183:Postoperative Complications / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology; D011300:Preoperative Care; D015996:Survival Rate
chemical_list: D000959:Antihypertensive Agents; D011464:Epoprostenol